Eu Yan Sang is Southeast Asia’s largest manufacturer and retailer of Chinese herbal medicine. It operates more than 210 stores and Chinese herbal medicine clinics, mainly across Singapore, Hong Kong and Malaysia.
Japanese companies, increasingly focused on growth, have stepped up major overseas acquisitions, including in Singapore. In March 2024, Sumitomo Life took control of the remaining shares in SingLife in a deal valuing the insurer at $4.6 billion, after first investing in the locally based group.
Last August, a joint venture between conglomerate Mitsui & Co and Rohto Pharmaceutical acquired a controlling stake in Eu Yan Sang International, a household name in this part of the world, at a valuation of $800 million.
